PAPER Femminella GD, Edison P
SEARCH RESULTS
331209 RESULTS
PAPER Hölscher C
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease.
Alzheimers Dement. 2014 Feb;10(1 Suppl):S47-54. PubMed: 24529525PAPER Foltynie T, Aviles-Olmos I
Exenatide as a potential treatment for patients with Parkinson's disease: first steps into the clinic.
Alzheimers Dement. 2014 Feb;10(1 Suppl):S38-46. PubMed: 24529524PAPER Hölscher C
First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
Alzheimers Dement. 2014 Feb;10(1 Suppl):S33-7. PubMed: 24529523PAPER Steculorum SM, Solas M, Brüning JC
The paradox of neuronal insulin action and resistance in the development of aging-associated diseases.
Alzheimers Dement. 2014 Feb;10(1 Suppl):S3-11. PubMed: 24529522PAPER De Felice FG, Lourenco MV, Ferreira ST
How does brain insulin resistance develop in Alzheimer's disease?
Alzheimers Dement. 2014 Feb;10(1 Suppl):S26-32. PubMed: 24529521PAPER Talbot K, Wang HY
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. PubMed: 24529520PAPER Bamne MN, Demirci FY, Berman S, Snitz BE, Rosenthal SL, Wang X, Lopez OL, Kamboh MI
Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
Neurobiol Aging. 2014 Jul;35(7):1779.e15-6. Epub 2014 Jan 23 PubMed: 24529499PAPER Guerrero-Berroa E, Schmeidler J, Beeri MS
Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.
Eur Neuropsychopharmacol. 2014 Jan 30; PubMed: 24529419PAPER Perez SE, He B, Nadeem M, Wuu J, Scheff SW, Abrahamson EE, Ikonomovic MD, Mufson EJ
Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer's Disease.
Biol Psychiatry. 2014 Jan 11; PubMed: 24529280PAPER Fujishiro H
Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
Psychogeriatrics. 2014 Jun;14(2):132-4. Epub 2014 Feb 16 PubMed: 24528871PAPER Klekociuk SZ, Summers MJ
Lowered performance in working memory and attentional sub-processes are most prominent in multi-domain amnestic mild cognitive impairment subtypes.
Psychogeriatrics. 2014 Mar;14(1):63-71. Epub 2014 Feb 16 PubMed: 24528806PAPER Ota K, Iseki E, Murayama N, Chiba Y, Fujishiro H, Kasanuki K, Manabe Y, Arai H, Sato K
Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.
Psychogeriatrics. 2014 Mar;14(1):72-80. Epub 2014 Feb 16 PubMed: 24528622PAPER Pey P, Pearce RK, Kalaitzakis ME, Griffin WS, Gentleman SM
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
Acta Neuropathol Commun. 2014 Feb 14;2(1):21. PubMed: 24528486PAPER Gomes S, Martins I, Fonseca AC, Oliveira CR, Resende R, Pereira CM
Protective effect of leptin and ghrelin against toxicity induced by amyloid-β oligomers in a hypothalamic cell line.
J Neuroendocrinol. 2014 Mar;26(3):176-85. PubMed: 24528254Current Filters
No filters selected